The End Game

In this episode of the Endgame podcast, Melissa Butterworth discusses the transformative impact of AI on the laboratory diagnostic industry. She explores how AI enhances diagnostic precision, streamlines workflows, and supports personalized medicine. The conversation highlights the significant growth of AI in pathology and its potential to revolutionize lab operations, making them more efficient and effective. Melissa emphasizes the urgency for labs to embrace AI technology to stay competitive in the evolving healthcare landscape.

In this inspiring episode of The End Game: Insiders on Your Side, host Melissa Butterworth sits down with Ravi Pulugurtha, Vice President of Operations at G3 Vision Labs, to explore the bold vision of delivering better healthcare everywhere for everyone. Ravi shares his journey from leading roles in healthcare technology to his current mission of transforming diagnostics—making them faster, more accessible, and patient-centric. He discusses how COVID-19 exposed the urgent need for timely test results, why now is the perfect time for innovation in healthcare, and the bold steps G3 Vision Labs is taking, including plans to go public, launching a patient-focused mobile app, and integrating AI to reduce errors. Listeners will gain insight into: * How rapid diagnostics can save lives and improve patient outcomes * G3 Vision Labs’ commitment to quality, trust, and transparency * The importance of staying true to values during rapid growth * The long-term vision for equitable, efficient, and responsive healthcare Whether you’re a senior lab executive, healthcare innovator, or simply passionate about improving patient care, this conversation will leave you inspired about the future of diagnostics.

How can artificial intelligence turn lab data into life-changing patient outcomes? In this episode of The End Game Insiders podcast, host Melissa Butterworth sits down with Brad Bostic, CEO of HC1, to explore how AI-powered healthcare analytics is reshaping the way we deliver care. From optimizing lab operations to driving value-based care, Brad shares how AI can: * Personalize patient care through lab-driven insights * Identify care gaps before they become crises * Improve operational efficiency and supply chain management * Help healthcare systems deliver better outcomes at lower costs Sound bites from the episode: 💬 "The lab is the place where the most value is—in its information." 💬 "It's all about how you maximize the value of these lab capabilities." 💬 "We are seeing a substantial shift toward value-based care." Whether you’re in healthcare leadership, lab operations, or passionate about the potential of healthcare technology, this episode offers a data-driven look at how AI is transforming the industry. 🎧 Listen now and see how the future of healthcare is being built today. #AI #HealthcareAnalytics #LabOperations #ValueBasedCare #HC1 #HealthcareInnovation #PatientCare #HealthcareTechnology #SupplyChainManagement

Join host Melissa Butterworth on "The End Game" as she explores the dynamic landscape of hospital systems and their strategic decisions to divest outreach programs. In this episode, Melissa discusses the financial, operational, and regulatory challenges prompting hospitals to reconsider their involvement in laboratory diagnostics. Learn about the significant transactions reshaping the industry. Tune in for an in-depth analysis of the healthcare market and its evolving priorities.

In this episode, host Melissa Butterworth sits down with Matt Honan, Vice President of Business Development at Sonic Healthcare, to explore why more and more health systems are choosing to monetize their lab outreach programs, enter management arrangements, and seek strategic partners. Together, they unpack what successful relationships between health systems and commercial labs really look like—from cultural alignment to long-term strategic value. Matt shares his insights into how buyers evaluate hospital outreach businesses, the key drivers behind higher valuations, and why these deals often take longer and look very different than traditional M&A transactions.